Finley Erin P, Hamilton Alison B, Canelo Ismelda, Jackson La Shawnta S, Lesser Rachel, Oberman Rebecca S, Yosef Julia, Chrystal Joya G, Fletcher Erica H, Bean-Mayberry Bevanne, Moin Tannaz, Farmer Melissa M, Lang Ariel J
Center for the Study of Healthcare Innovation, Implementation, and Policy (CSHIIP), VA Greater Los Angeles Healthcare System, Los Angeles, CA, USA.
Long School of Medicine, UT Health Science Center San Antonio, San Antonio, TX, USA.
BMC Health Serv Res. 2025 May 23;25(1):746. doi: 10.1186/s12913-025-12871-x.
Reach Out, Stay Strong Essentials (ROSE) is an evidence-based intervention for preventing post-partum depression being implemented across U.S. Veterans Health Administration (VA) sites as part of the EMPOWER 2.0 implementation trial comparing Replicating Effective Programs (REP) and Evidence-Based Quality Improvement (EBQI) strategies for improving women's health care. As both REP and EBQI support adaptation to meet local needs, the EMPOWER 2.0 implementation team and participating sites have collaboratively developed adaptations of ROSE to better serve pregnant veterans. We describe contextual conditions arising during the first three years of implementation, associated adaptations to the intervention and implementation approach, and implications for pragmatic tailoring and diffusion of evidence-based interventions.
We conducted a qualitative case study that included rapid qualitative analysis of 50 periodic reflections (brief guided discussions with templated notes) completed with EMPOWER 2.0 implementation team members February 2021-February 2024. Contextual conditions were characterized according to domains of the updated Consolidated Framework for Implementation Research (CFIR); adaptations were characterized using the Framework for Reporting Adaptations and Modifications to Evidence-Based Interventions (FRAME) and Framework for Reporting Adaptations and Modifications to Evidence-based Implementation Strategies (FRAME-IS).
Sites reported high demand for ROSE in response to perceived gaps in care for pregnant veterans' mental health needs. Site-level challenges included the need to locate ROSE within existing services, although the salience of contextual conditions evolved across implementation phases. Notable adaptations included updates to the ROSE intervention (e.g., improving alignment with VA clinical practice guidelines) and adaptations to the implementation approach (e.g., offering training to VA providers beyond the original EMPOWER sites). Although the trial is ongoing, expansion of ROSE training has resulted in a total of 256 VA providers trained across 48 VA facilities nationwide.
In implementing ROSE across a national sample of VA sites, co-produced adaptations emerged to improve feasibility of delivery and increase acceptability of ROSE for pregnant veterans. Implementation of ROSE in EMPOWER 2.0 provides a pragmatic model for supporting rapid iteration and diffusion of adaptations to address perinatal mental health needs within large healthcare systems.
ClinicalTrials.gov: Enhancing Mental and Physical Health of Women Veterans (NCT05050266). Registration Date: 09/09/2021. https://clinicaltrials.gov/study/NCT05050266?term=EMPOWER%202.0&rank=1 .
“伸出援手,保持坚强要素”(ROSE)是一项基于证据的预防产后抑郁症的干预措施,作为“增强权能2.0”实施试验的一部分,正在美国退伍军人健康管理局(VA)各站点实施,该试验比较了复制有效项目(REP)和基于证据的质量改进(EBQI)策略以改善妇女医疗保健。由于REP和EBQI都支持根据当地需求进行调整,“增强权能2.0”实施团队和参与站点共同开发了ROSE的改编版本,以更好地服务怀孕退伍军人。我们描述了实施的前三年中出现的背景情况、对干预措施和实施方法的相关改编,以及对基于证据的干预措施进行务实调整和推广的影响。
我们进行了一项定性案例研究,包括对2021年2月至2024年2月期间与“增强权能2.0”实施团队成员完成的50次定期反思(带有模板化笔记的简短引导式讨论)进行快速定性分析。根据更新后的实施研究综合框架(CFIR)的领域对背景情况进行了描述;使用基于证据的干预措施改编和修改报告框架(FRAME)以及基于证据的实施策略改编和修改报告框架(FRAME-IS)对改编进行了描述。
各站点报告称,由于认识到怀孕退伍军人心理健康需求护理方面存在差距,对ROSE的需求很高。站点层面的挑战包括需要将ROSE纳入现有服务中,尽管背景情况的突出性在实施阶段有所演变。显著的改编包括对ROSE干预措施的更新(例如,使其与VA临床实践指南更好地保持一致)以及对实施方法的改编(例如,向最初的“增强权能”站点以外的VA提供者提供培训)。尽管试验仍在进行中,但ROSE培训的扩展已导致全国48个VA设施的256名VA提供者接受了培训。
在全国范围内的VA站点样本中实施ROSE时,出现了共同产生的改编版本,以提高提供的可行性并增加ROSE对怀孕退伍军人的可接受性。在“增强权能2.0”中实施ROSE为支持快速迭代和改编的推广提供了一个务实模型,以满足大型医疗系统内的围产期心理健康需求。
ClinicalTrials.gov:增强退伍军人女性的身心健康(NCT05050266)。注册日期:2021年9月9日。https://clinicaltrials.gov/study/NCT05050266?term=EMPOWER%202.0&rank=1 。